Cytokinetics
CYTK
#2440
Rank
C$10.13 B
Marketcap
C$72.78
Share price
-1.32%
Change (1 day)
-20.00%
Change (1 year)

EPS for Cytokinetics (CYTK)

EPS in 2026 (TTM): C-$8.46

According to Cytokinetics 's latest financial reports the company's current EPS (TTM) is C-$8.66. In 2025 the company made an earnings per share (EPS) of C-$9.36 a decrease over its 2024 EPS that were of C-$7.54.

EPS history for Cytokinetics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$8.46-9.64%
2025C-$9.3624.14%
2024C-$7.54-3.49%
2023C-$7.8128.24%
2022C-$6.0950.18%
2021C-$4.0640.8%
2020C-$2.88
2018C-$2.79-24.12%
2017C-$3.68-776.32%
2016C$0.54-139.18%
2015C-$1.39125.58%
2014C-$0.62-67.67%
2013C-$1.91-44.58%
2012C-$3.44

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
C$24.91-387.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
C-$49.79 475.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$3.71-142.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
C-$72.11 732.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
C-$1.65-80.96%๐Ÿ‡บ๐Ÿ‡ธ USA